{
    "organizations": [],
    "uuid": "e5bfd5977a2398a5648f86d09446810b030ed8e1",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-wave-life-sciences-and-takeda-form/brief-wave-life-sciences-and-takeda-form-strategic-collaboration-to-advance-therapies-for-central-nervous-system-disorders-idUSFWN1QA0JW",
    "ord_in_thread": 0,
    "title": "BRIEF-Wave Life Sciences And Takeda Form Strategic Collaboration To Advance Therapies For Central Nervous System Disorders",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "Feb 20 (Reuters) - Takeda Pharmaceutical Co Ltd:\n* WAVE LIFE SCIENCES AND TAKEDA FORM GLOBAL STRATEGIC COLLABORATION TO ADVANCE THERAPIES FOR CENTRAL NERVOUS SYSTEM DISORDERS\n* WAVE LIFE SCIENCES LTD - UNDER COLLABORATION, CO TO PROVIDE TAKEDA OPTION TO CO-DEVELOP AND CO-COMMERCIALIZE PROGRAMS IN HUNTINGTON‘S DISEASE\n* WAVE LIFE SCIENCES - CO WILL ALSO PROVIDE TAKEDA OPTION TO CO-DEVELOP AND CO-COMMERCIALIZE PROGRAMS IN AMYOTROPHIC LATERAL SCLEROSIS, AMONG OTHERS\n* WAVE LIFE SCIENCES LTD - UNDER TERMS OF TWO-COMPONENT AGREEMENT, TAKEDA WILL MAKE AN INITIAL PAYMENT OF $110 MILLION TO WAVE\n* WAVE LIFE SCIENCES LTD - UNDER TERMS OF TWO-COMPONENT AGREEMENT, TAKEDA WILL PURCHASE $60 MILLION OF WAVE‘S ORDINARY SHARES AT $54.70 PER SHARE\n* WAVE LIFE SCIENCES LTD - TAKEDA WILL ALSO FUND AT LEAST $60 MILLION OF WAVE RESEARCH OVER A FOUR-YEAR PERIOD\n* WAVE LIFE SCIENCES - TAKEDA TO HAVE RIGHT TO LICENSE MULTIPLE PRECLINICAL PROGRAMS TARGETING CNS DISORDERS Source text for Eikon: Further company coverage: (Bangalore.newsroom@thomsonreuters.com)\n ",
    "published": "2018-02-20T20:28:00.000+02:00",
    "crawled": "2018-02-21T21:17:17.011+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "feb",
        "reuters",
        "takeda",
        "pharmaceutical",
        "co",
        "ltd",
        "wave",
        "life",
        "science",
        "takeda",
        "form",
        "global",
        "strategic",
        "collaboration",
        "advance",
        "therapy",
        "central",
        "nervous",
        "system",
        "disorder",
        "wave",
        "life",
        "science",
        "ltd",
        "collaboration",
        "co",
        "provide",
        "takeda",
        "option",
        "program",
        "huntington",
        "disease",
        "wave",
        "life",
        "science",
        "co",
        "also",
        "provide",
        "takeda",
        "option",
        "program",
        "amyotrophic",
        "lateral",
        "sclerosis",
        "among",
        "others",
        "wave",
        "life",
        "science",
        "ltd",
        "term",
        "agreement",
        "takeda",
        "make",
        "initial",
        "payment",
        "million",
        "wave",
        "wave",
        "life",
        "science",
        "ltd",
        "term",
        "agreement",
        "takeda",
        "purchase",
        "million",
        "wave",
        "ordinary",
        "share",
        "per",
        "share",
        "wave",
        "life",
        "science",
        "ltd",
        "takeda",
        "also",
        "fund",
        "least",
        "million",
        "wave",
        "research",
        "period",
        "wave",
        "life",
        "science",
        "takeda",
        "right",
        "license",
        "multiple",
        "preclinical",
        "program",
        "targeting",
        "cns",
        "disorder",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}